Clinical Trial

Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

Recruiting
View on ClinicalTrials.gov →
Summary
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2017-05-12.
Trial Details
NCT Number NCT03154697
Lead Sponsor Vanda Pharmaceuticals
Conditions Sleep Disturbances in Smith-Magenis Syndrome
Enrollment 1,000 participants
Start Date 2016-01
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2024-03-20